We are live on
!
Find out more
ATYR
aTyr Pharma
ATYR
ATYR
111 hedge funds and large institutions have $43.7M invested in aTyr Pharma in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 8
174% more call options, than puts
Call options by funds: $766K | Put options by funds: $280K
32% more funds holding
Funds holding: 84 → 111 (+27)
1.21% more ownership
Funds ownership: 55.96% → 57.17% (+1.2%)
10% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 30
22% less capital invested
Capital invested by funds: $55.7M → $43.7M (-$12M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
111
Holders Change
+27
Holders Change %
+32.14%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
36
Increased
27
Reduced
30
Closed
8
Calls
$766K
Puts
$280K
Net Calls
+$486K
Net Calls Change
+$215K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.89M |
| 2 |
Millennium Management
New York
|
+$1.39M |
| 3 |
Two Sigma Investments
New York
|
+$583K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$149K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$117K |
